S025 Complications of Cosmetic Procedures
DESCRIPTION
A significant number of cosmetic procedures are currently performed by dermatologists on daily bases. The earliest diagnose is crucial for an effective management of any complication. Complications can vary from bad cosmetic results to the severe complications, such as embolism, blindness and/or disfiguring scars. This session aims to discuss complications and share recent knowledge on their management.
LEARNING OBJECTIVES
Manage the most important complications that may arise from frequent cosmetic procedures.
Identify the earlier signs and symptoms of most important complications of cosmetic procedures.
Effectively treat complications of the most frequent cosmetic procedures.
SCHEDULE
9:00 AM
Introduction
9:06 AM
When Aesthetics Go Wrong: Scar Rescue Strategies - Gisele Viana
Gisele Viana Oliveira, MD, MSc, PhD, IFAAD
9:20 AM
Mycobacteriosis after cosmetic procedures: Recognition, Diagnosis and management
Samira Yarak, MD, IFAAD
9:34 AM
Uncommon Complications of Common Cosmetic Procedures
Hassan I. Galadari, MD, FAAD
9:48 AM
Ultrasound: The Game Changer in Aesthetics Top 5 Key Applications
10:02 AM
Q & A
10:10 AM
Respecting the Chemicals: avoiding complications for each active ingredient in Chemical Peeling
Carlos G. Wambier, MD, FAAD
10:24 AM
- Adverse Effects Linked to EBDs – and How to Treat Them.
10:38 AM
Complications of laser treatments
10:52 AM
- DON (Delayed-Onset Nodules) after Hyaluronic Acid Fillers: Are They All the Same?
Gabriela Helena Munhoz da Fontoura, MD
11:06 AM
- The Regenerative Era: Science, Hype and Complications
Maria Fernanda C. Tembra, MD
11:20 AM
- Permanent Fillers: The Role of Immunity, Complications, and Emerging Treatments
Mayra Ianhez, MD
11:34 AM
botulinum toxins: case presentations: unfolding undesirable outcomes
Joely Kaufman, MD, FAAD
11:48 AM
Q & A
11:48 AM
Complications of lasers and its management
DIRECTOR
Doris M. Hexsel, MD, IFAAD
Hexsel Dermatologic Clinics - Private Clinics Rio de Janeiro and Porto Alegre, Brazil.
SPEAKERS
Fernanda Cavallieri
Hassan I. Galadari, MD, FAAD
United Arab Emirates University
Mayra Ianhez, MD
Federal University of Goiás and Hospital of Tropical Diseases
Joely Kaufman, MD, FAAD
Gabriela Helena Munhoz da Fontoura, MD
Brazilian Study Group on Dermatologic Procedures and Their Complications.
Gisele Viana Oliveira, MD, MSc, PhD, IFAAD
Faculdade de Ciencias Medicas de Minas Gerais, Brazil
Maria Fernanda C. Tembra, MD
Carlos G. Wambier, MD, FAAD
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery University of Miami, Miller School of Medicine
Samira Yarak, MD, IFAAD
Federal University of São Paulo
DISCLOSURES
Fernanda Cavallieri
No financial relationships exist with ineligible companies.
Hassan I. Galadari, MD, FAAD
No financial relationships exist with ineligible companies.
Doris M. Hexsel, MD, IFAAD
Baiersdorf Eucerin – Speaker(Fees); Galderma – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Rennova – Speaker(Fees);
Mayra Ianhez, MD
AbbVie – Advisory Board(Fees), Speaker(Fees); Galderma Brasil Ltda – Advisory Board(Fees), Speaker(Fees); Janssen Pharmaceuticals, Inc – Advisory Board(Fees), Speaker(Fees); Pfizer Inc. – Advisory Board(Fees), Speaker(Fees); Sanofi Genzyme – Advisory Board(Fees), Speaker(Fees);
Joely Kaufman, MD, FAAD
Allergan, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Galderma USA – Advisory Board(Honoraria), Investigator(Fees); Jetema – Investigator(Grants/Research Funding); Johnson and Johnson – Investigator(Grants/Research Funding); L'Oreal – Investigator(Grants/Research Funding); Neutrogena Corporation – Advisory Board(Honoraria); OneSkin – Consultant (1099 relationship)(Honoraria); Revance Therapeutics, Inc. – Investigator(Fees); Silk Medical Aesthetics Inc. – Investigator(Grants/Research Funding); TEOXANE Laboratories – Consultant (1099 relationship)(Fees), Investigator(Fees);
Gabriela Helena Munhoz da Fontoura, MD
No financial relationships exist with ineligible companies.
Gisele Viana Oliveira, MD, MSc, PhD, IFAAD
LMG – Speaker(Other Financial Benefit); Vydence Medical – Speaker(Other Financial Benefit);
Maria Fernanda C. Tembra, MD
No financial relationships exist with ineligible companies.
Carlos G. Wambier, MD, FAAD
Allergan, Inc. – Advisory Board(Fees); Applied Biology – Advisory Board(Fees); ChemistryRx – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Cynosure – Speaker/Faculty Education(Fees); Daniel Alain – Advisory Board(Fees); Eli Lilly – Investigator(Grants/Research Funding); Galderma Brasil Ltda – Speaker(Fees); Incyte – Advisory Board(Fees); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker(Fees); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); UCB – Investigator(Grants/Research Funding); Wambier Dermatologics, LLC – Founder(Other Financial Benefit); Young Pharmaceuticals – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights);
Samira Yarak, MD, IFAAD
No financial relationships exist with ineligible companies.